Female carriers of a BRCA1/2 genetic mutation, not already affected by cancer, have up to 85 and 60% lifetime risks of developing breast and ovarian cancer, respectively (Ford et al, 1998). The gene discussed is BRCA1; the disease is ovarian cancer.